GeneFerm Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	15.7	28.86	-22.53	124.62	93.45	57.41
Depreciation & Amortization	73.53	74.48	79.36	73.49	50.03	45.36
Loss (Gain) From Sale of Assets	-0.05	0.28	-0.02	-0.01	0.11	-0.04
Provision & Write-off of Bad Debts	-0.02	-0.04	-1.09	-0.43	-0.72	1.44
Other Operating Activities	-1.55	0.05	-34.31	5.11	1.06	24.97
Change in Accounts Receivable	12.29	-3.94	11.92	-6.86	4.51	-33.4
Change in Inventory	-25.08	-18.82	-15.47	-9.38	-30.94	-8.14
Change in Accounts Payable	2.06	3.64	3.94	-3.23	0.19	-0.43
Change in Unearned Revenue	9.96	11.46	6.71	-1.85	-0.67	1.33
Change in Other Net Operating Assets	-0.53	3.35	-20.42	8.85	5.4	23.72
Operating Cash Flow	86.31	99.31	8.09	190.31	122.43	112.23
Operating Cash Flow Growth	323.41%	1127.59%	-95.75%	55.44%	9.09%	98.93%
Capital Expenditures	-25.22	-23.42	-22.4	-69.94	-278.18	-144.88
Sale of Property, Plant & Equipment	0.05	0.21	0.03	0.01	0.04	0.04
Sale (Purchase) of Intangibles	-	-	-0.3	-1.46	-0.24	-0.72
Other Investing Activities	0.18	0.63	-0.16	0.78	-1.95	0.31
Investing Cash Flow	-24.98	-22.59	-22.83	-70.62	-280.33	-145.26
Short-Term Debt Issued	-	50	80	240	45	-
Long-Term Debt Issued	-	120	171	-	-	5
Total Debt Issued	50	170	251	240	45	5
Short-Term Debt Repaid	-	-50	-120	-245	-	-
Long-Term Debt Repaid	-	-38.94	-31.7	-32.68	-285.33	-74.17
Total Debt Repaid	-89.75	-88.94	-151.7	-277.68	-285.33	-74.17
Net Debt Issued (Repaid)	-39.75	81.06	99.3	-37.68	-240.33	-69.17
Issuance of Common Stock	-	-	-	-	-	297.36
Common Dividends Paid	-	-	-82.92	-62.19	-41.46	-3.39
Financing Cash Flow	-39.75	81.06	16.38	-99.87	-281.79	224.81
Foreign Exchange Rate Adjustments	0.12	0.02	0.65	-0.36	0.76	-0.19
Net Cash Flow	21.7	157.81	2.3	19.46	-438.92	191.59
Free Cash Flow	61.09	75.89	-14.31	120.37	-155.74	-32.65
Free Cash Flow Margin	9.20%	11.21%	-2.74%	15.17%	-24.57%	-6.25%
Free Cash Flow Per Share	1.47	1.83	-0.34	2.89	-3.66	-0.70
Cash Interest Paid	6.15	6.15	4.42	4.15	2.74	1.23
Cash Income Tax Paid	0.16	0.16	34.43	20.28	20.86	-1.97
Levered Free Cash Flow	122.73	65.09	-14.32	67.65	-169.4	-49.01
Unlevered Free Cash Flow	126.65	68.98	-11.55	70.26	-167.01	-44.44
Change in Working Capital	-1.3	-4.32	-13.32	-12.47	-21.5	-16.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.